10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 256 filers reported holding 10X GENOMICS INC in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $642 | -38.9% | 33 | +17.9% | 0.00% | – |
Q1 2024 | $1,051 | -32.9% | 28 | 0.0% | 0.00% | – |
Q4 2023 | $1,567 | +35.7% | 28 | 0.0% | 0.00% | – |
Q3 2023 | $1,155 | -62.0% | 28 | -50.0% | 0.00% | – |
Q2 2023 | $3,041 | +105.9% | 56 | +100.0% | 0.00% | – |
Q1 2023 | $1,477 | +36825.0% | 28 | -62.2% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 74 | -56.7% | 0.00% | – |
Q3 2022 | $14,000 | 0.0% | 171 | +1.2% | 0.00% | – |
Q2 2022 | $14,000 | -22.2% | 169 | -23.9% | 0.00% | – |
Q1 2022 | $18,000 | +260.0% | 222 | +534.3% | 0.00% | – |
Q4 2021 | $5,000 | +25.0% | 35 | +25.0% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 28 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | – | 28 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 10 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2019 | $47,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |